Gene interactions and pathways from curated databases and text-mining

◀ Back to PTPN11

EGFR — PTPN11

Pathways - manually collected, often from reviews:

Protein-Protein interactions - manually collected from original source literature:

Studies that report less than 10 interactions are marked with *

Text-mined interactions from Literome

Chen et al., Nat Genet 2000 (Abnormalities, Multiple...) : Our results identify the Egfr and Shp2 as components of a growth-factor signalling pathway required specifically for semilunar valvulogenesis, support the hypothesis that Shp2 is required for Egfr signalling in vivo, and provide an animal model for aortic valve disease
Wu et al., Oncogene 2000 (Brain Neoplasms...) : These data reveal a pathway that negatively regulates EGFR induced PI3-K activation in glioblastoma cells and involves interactions between SHP2 and tyrosine phosphorylated SIRPalpha1
Agazie et al., Mol Cell Biol 2003 : Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling
Goldshmit et al., J Biol Chem 2004 : Overexpression of the phosphatase SHP-2 reduced the constitutive EGFR phosphorylation and subsequent neurite outgrowth
Rafiq et al., Circ Res 2008 : These results show that Cat.G induced cardiomyocyte apoptosis involves an increase in EGFR dependent activation of SHP2 that promotes focal adhesion kinase dephosphorylation and subsequent cardiomyocyte anoikis
Sampaio et al., Mol Cell Biol 2008 : Indeed, by up- and down-regulation of signal strength in different cell lines and through different methods, we observed that Gab1/Shp2 and Ras/ERK1-2 in concert become independent of PI3K upon strong epidermal growth factor receptor (EGFR) stimulation and dependent on PI3K upon limited EGFR activation
Zhou et al., Cell Death Differ 2008 (Breast Neoplasms...) : However, the role of SHP2 in aberrant EGFR and human EGFR2 ( HER2 ) signaling and cancer, particularly in breast cancer, has not been investigated
Furcht et al., Oncogene 2013 (Carcinoma, Non-Small-Cell Lung...) : In cells expressing EGFR mutants, which do not undergo efficient ligand mediated endocytosis, SHP2 was basally associated with GRB2 associated binder 1 (GAB1) and EGFR, and SHP2 's presence in membrane fractions was dependent on EGFR activity
Deb et al., J Biol Chem 1998 : Dominant negative forms of SHP-2 had no effect on EGF stimulated interaction of GRB2 with EGFR or SHC, nor did they influence phosphorylation of SHC and SHC/EGFR association